FOR IMMEDIATE RELEASE – March 20, 2012
CONTACT: Dennis McNannay, Executive Director, Oregon Bioscience Assoc., (503) 548-4432
Dianne Danowski Smith, Oregon Bio board member, (503) 201-7019
OREGON BIOSCIENCE ASSOCIATION ANNOUNCES BOARD OFFICERS AND DIRECTORS FOR 2012
(Portland, Ore.) — Peter Murray, site executive and vice president for one of Oregon’s largest medical device manufacturers, Welch Allyn, has been appointed chairman of the Oregon Bioscience Association (Oregon Bio) board of directors. Executive committee members include Ryan Dunlap, treasurer, Moss Adams LLP; and Michael Phillips, secretary and general counsel, Davis Wright Tremaine LLP. Other executive committee members include Abhijit Banerjee, Oregon Health & Science University; Gordon Brown, Yecuris Corp.; Bill Carroll, Meagan Medical/RS Medical; Juergen Lindner, Biotronik USA; Adrian Polliack, SAM Medical; and Matt Smits, TE Connectivity.
Along with the officers, serving on Oregon Bio’s Board of Directors for 2012 will be Mark Ahn, Galena Biopharma, Inc.; Patricia Beckmann, OTRADI; Phil Benz, Advanced Vascular Dynamics; Len Blackstone, Blackstone Inc.; Dianne Danowski Smith, Publix Northwest; Will Fox, Welch Allyn; Nathan Gibson, Skanska USA; and Mark Haldeman, Advanced Technology Group, Inc.
Also serving on the board are Geoff Hall, Precision Wire Components; Nancy Lime, Oligos Etc.;
Ralph Makar, business executive and industry consultant; Bill Newman, Northwest Technology Ventures; Ketan Paranjape, Intel Digital Health; Steven Prewitt, Schwabe Williamson & Wyatt; Larry Sanders, Genentech; Ron Sherman, Silicon Valley Bank; and Jennifer Stoll, Allergan.
About Oregon Bioscience Association
The Oregon Bioscience Association advocates for its members and the industry to create opportunity through community, collaboration and commercialization. Oregon Bio promotes the growth and quality of the bioscience industry in Oregon and continually seeks ways to support sustainability and growth in the life science, bioscience, biotechnology and device manufacturing industries and to create acceleration initiatives so members can achieve their full scientific, economic and social potential. Oregon Bio, a nonprofit membership association, is the Oregon affiliate of the Biotechnology Industry Organization.
The association’s most current economic impact study showed that Oregon has 631 bioscience establishments and 13 life science research institutions generating a cumulative $7.1 billion in economic activity, 36,800 jobs, $1.9 billion in personal income and $273.9 million in local and state tax revenues. More about the Oregon Bioscience Association can be found at www.oregonbio.org.